176 related articles for article (PubMed ID: 27992009)
1. Development of exclusively cutaneous sarcoidosis in patient with rheumatoid arthritis during treatment with etanercept.
Vieira MA; Saraiva MI; Silva LK; Fraga RC; Kakizaki P; Valente NY
Rev Assoc Med Bras (1992); 2016 Nov; 62(8):718-720. PubMed ID: 27992009
[TBL] [Abstract][Full Text] [Related]
2. Systemic sarcoidosis induced by etanercept: first Brazilian case report.
Unterstell N; Bressan AL; Serpa LA; Fonseca e Castro PP; Gripp AC
An Bras Dermatol; 2013; 88(6 Suppl 1):197-9. PubMed ID: 24346918
[TBL] [Abstract][Full Text] [Related]
3. Acute kidney injury due to renal sarcoidosis during etanercept therapy: a case report and literature review.
Akiyama M; Kaneko Y; Hanaoka H; Kuwana M; Takeuchi T
Intern Med; 2015; 54(9):1131-4. PubMed ID: 25948363
[TBL] [Abstract][Full Text] [Related]
4. Sarcoidosis during etanercept treatment for rheumatoid arthritis in women with a history of bilateral oophorectomy.
Sawahata M; Sigiyama Y; Yamasawa H; Miki A; Yamamoto H; Muto S; Yamamoto H; Bando M
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Aug; 33(2):178-81. PubMed ID: 27537723
[TBL] [Abstract][Full Text] [Related]
5. Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients.
Verschueren K; Van Essche E; Verschueren P; Taelman V; Westhovens R
Clin Rheumatol; 2007 Nov; 26(11):1969-71. PubMed ID: 17340045
[TBL] [Abstract][Full Text] [Related]
6. [Case Report; Long-term treatment with etanercept induced systemic sarcoidosis in a patient with rheumatoid arthritis].
Yokoe I; Haraoka H; Yonamine T; Sato R; Nishiwaki A; Takei M
Nihon Naika Gakkai Zasshi; 2015 Apr; 104(4):769-74. PubMed ID: 26536740
[No Abstract] [Full Text] [Related]
7. [Sarcoidosis after adalimumab treatment in inflammatory rheumatic diseases: a report of two cases and literature review].
Scailteux LM; Guedes C; Polard E; Perdriger A
Presse Med; 2015 Jan; 44(1):4-10. PubMed ID: 25534463
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous pseudolymphoma associated with a TNF-alpha inhibitor treatment: etanercept.
Guis S; Schiano de Colella JM; Bonnet N; Andrac-Meyer L; Balandraud N; Mattei JP; Franck B; Roudier C; Roudier J; Berbis P
Eur J Dermatol; 2008; 18(4):474-6. PubMed ID: 18573737
[No Abstract] [Full Text] [Related]
9. Tumor necrosis factor-alpha antagonist-induced sarcoidosis.
Clementine RR; Lyman J; Zakem J; Mallepalli J; Lindsey S; Quinet R
J Clin Rheumatol; 2010 Sep; 16(6):274-9. PubMed ID: 20808167
[TBL] [Abstract][Full Text] [Related]
10. Sarcoidosis occuring during anti-TNF-alpha treatment for inflammatory rheumatic diseases: report of two cases.
Toussirot E; Pertuiset E; Kantelip B; Wendling D
Clin Exp Rheumatol; 2008; 26(3):471-5. PubMed ID: 18578973
[TBL] [Abstract][Full Text] [Related]
11. Development of cutaneous sarcoidosis during treatment with tumour necrosis alpha factor antagonists.
Lamrock E; Brown P
Australas J Dermatol; 2012 Nov; 53(4):e87-90. PubMed ID: 23157794
[TBL] [Abstract][Full Text] [Related]
12. Development of sarcoidosis during etanercept therapy.
Ishiguro T; Takayanagi N; Kurashima K; Matsushita A; Harasawa K; Yoneda K; Tsuchiya N; Miyahara Y; Yamaguchi S; Yano R; Tokunaga D; Saito H; Ubukata M; Yanagisawa T; Sugita Y; Kawabata Y
Intern Med; 2008; 47(11):1021-5. PubMed ID: 18520114
[TBL] [Abstract][Full Text] [Related]
13. Sarcoidosis: an underestimated and potentially severe side effect of anti-TNF-alpha therapy.
Vigne C; Tebib JG; Pacheco Y; Coury F
Joint Bone Spine; 2013 Jan; 80(1):104-7. PubMed ID: 22885144
[No Abstract] [Full Text] [Related]
14. Lung sarcoidosis induced by TNF antagonists in rheumatoid arthritis: a case presentation and a literature review.
Gifre L; Ruiz-Esquide V; Xaubet A; Gómez-Puerta JA; Hernández MV; Sanmartí R
Arch Bronconeumol; 2011 Apr; 47(4):208-12. PubMed ID: 20638761
[TBL] [Abstract][Full Text] [Related]
15. Mitral valve granulomatosis: A paradoxical reaction complicating etanercept treatment in rheumatoid arthritis. A case report.
Ngoufack C; Semerano L; Podglajen I; Bruneval P; Meune C; Valeyre D; Dhote R; Boissier MC; Saidenberg-Kermanac'h N
Joint Bone Spine; 2021 Jul; 88(4):105183. PubMed ID: 33838309
[TBL] [Abstract][Full Text] [Related]
16. Uveitis associated with sarcoidosis exacerbated by etanercept therapy.
Suzuki J; Goto H
Jpn J Ophthalmol; 2009 Jul; 53(4):439-40. PubMed ID: 19763766
[No Abstract] [Full Text] [Related]
17. Development of pulmonary and cardiac sarcoidosis during etanercept therapy.
Miyagi R; Ideguchi H; Soga T; Yamakawa Y; Otsuki H; Niino H; Shiina T; Ueda A; Ishigatsubo Y
Int J Rheum Dis; 2014 Sep; 17(7):810-2. PubMed ID: 24460777
[No Abstract] [Full Text] [Related]
18. [Severe hypercalcemia revealing sarcoidosis precipitated by etanercept].
Watrin A; Royer M; Legrand E; Gagnadoux F
Rev Mal Respir; 2014 Mar; 31(3):255-8. PubMed ID: 24680117
[TBL] [Abstract][Full Text] [Related]
19. Development of Propionibacterium acnes-associated Sarcoidosis During Etanercept Therapy.
Isshiki T; Matsuyama H; Sakamoto S; Honma N; Mikami T; Shibuya K; Eishi Y; Homma S
Intern Med; 2019 May; 58(10):1473-1477. PubMed ID: 30626837
[TBL] [Abstract][Full Text] [Related]
20. A case of clinically amyopathic dermatomyositis that developed during anti-TNF-α therapy for rheumatoid arthritis.
Takata M; Yamasaki A; Yamada N; Hagino H; Funaki Y; Harada T; Okazaki R; Hasegawa Y; Fukushima T; Morita M; Sueda Y; Yamamoto A; Shimizu E
Allergol Int; 2018 Apr; 67(2):286-288. PubMed ID: 28964642
[No Abstract] [Full Text] [Related]
[Next] [New Search]
